SMTL ID : 3qkm.1

Spirocyclic sulfonamides as AKT inhibitors

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

monomer

Ligands

1 x SM9: N-(2-ETHOXYETHYL)-N-{(2S)-2-HYDROXY-3-[(5R)-2-(QUINAZOLIN-4-YL)-2,7-DIAZASPIRO[4.5]DEC-7-YL]PROPYL}-2,6-DIMETHYLBENZENESULFONAMIDE(Non-covalent)

SM9.1: 25 residues within 4Å: Chain A: L.17, G.18, K.19, G.20, T.21, F.22, G.23, K.24, V.25, A.38, K.40, L.42, I.47, E.52, T.72, M.88, E.89, Y.90, A.91, E.95, E.139, M.142, T.152, D.153, F.299 17 PLIP interactions: 17 interactions with chain A Hydrophobic interactions: A:V.25, A:A.38, A:L.42, A:I.47, A:E.52, A:T.72, A:E.95, A:T.152 Hydrogen bonds: A:F.22, A:G.23, A:A.91 Water bridges: A:T.21, A:T.152, A:D.153 Salt bridges: A:E.139, A:D.153, A:D.153

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Xu, R. et al., Discovery of spirocyclic sulfonamides as potent Akt inhibitors with exquisite selectivity against PKA. Bioorg.Med.Chem.Lett. (2011)

Release Date

2011-04-06

Peptides

RAC-alpha serine/threonine-protein kinase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

RAC-alpha serine/threonine-protein kinase

Related Entries With Identical Sequence